IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Crescent Biopharma Inc.

CUSIP: 38000Q201 | 3 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/ABalyasny Asset Management L.P.1,662,9176.0%New 5%+ stakeJun 30, 2026No 13F filer matched
13G/ABalyasny Asset Management L.P.1,662,917
6.0% of class · Jun 30, 2026

Institutional Holders — Q2 2026

Boxer Capital Management, LLC453,686
0.6% of portfolio›$8.2M
Quadrature Capital Ltd19,227
0.0% of portfolio›$346.1K
StyleTurnoverLocationFiled
Boxer Capital Management, LLC
453,686$8.2M0.6%Agg GrowthMediumSan Diego, CA2026-08-14
Quadrature Capital Ltd
19,227$346.1K0.0%GARPVery HighLondon, United Kingdom2026-08-07
New 5%+ stake
No 13F filer matched